Wednesday, 06. November 2024 Share: YouTube RSS

Eli Lilly’s stock tumbles as Mounjaro, Zepbound sales miss by wide margins

Eli Lilly’s stock heads for biggest selloff since 2008 after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Source: MarketWatch

Continue reading...

Related Articles

×